Patent · US Active

Group A streptococcus vaccine

US10513544B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

GRIFFITH UNIVERSITY · AU

Inventors

Manisha Pandey · Forsayth, AU
Michael Batzloff · Calle de la Era, AU
Michael Good · Forsayth, AU

Key dates

Filing date	Apr 30, 2019
Grant date	Dec 24, 2019
Priority date	—
Expiry date	Apr 30, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to methods of eliciting an immune response to group A streptococcal bacteria in a mammal, the method including the step of administering to the mammal an effective amount of a composition comprising an isolated p145 peptide of SEQ ID NO: 56 and/or a p145 peptide variant having an amino acid sequence at least 90% identical to SEQ ID NO: 56, and an isolated SpyCEP peptide of SEQ ID NO: 18 and/or a SpyCEP peptide variant having an amino acid sequence at least 90% identical to SEQ ID NO: 18.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.